Statistics
Publications
25
Citations
2.2K
H-Index
20
Active since
1991
Andrew E. Parker is an author at AstraZeneca (United Kingdom) specializing in life sciences, molecular biology, and cell biology.
Publications per year
1991–2024
25
25
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Hazel Tye, Catherine L. Kennedy, Meri Najdovska et al. · Cancer Cell · 2012 · 275 citations · Full text
Medicine, Immunology, Oncology +14
Grant N. Wheeler, Andrew E. Parker, C. Thomas et al. · Proceedings of the National Academy of Sciences · 1991 · 182 citations
1–5 of 25